Delivery Order SPE2DB22D1106-SPE2DB25FEVY7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This contract award, valued at $7,352.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567308258 INGREZZA 40 MG CAPSULE 30S, a specialty medication, with a completion date of March 12, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,049.61 firm fixed-price contract is for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and was awarded on December 26, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, valued at $3,676.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of INGREZZA 40 MG CAPSULE 30S, a prescription drug product. The contract has an ultimate completion date of April 23, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The contract has a ceiling value of $4,027.70 and a completion date of July 30, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,676.12 and a period of performance through July 18, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INGREZZA 40 MG CAPSULES 30S, a pharmaceutical product, with a ceiling value of $11,028.36 and a performance period through June 9, 2025. The contract is not set aside and is awarded as part of AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,676.12, is for the delivery of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of June 10, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of INGREZZA 40 MG CAPSULE 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,352.24 and a period of performance through July 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.55 firm fixed price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of February 6, 2023 and was awarded on January 13, 2023. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEVY7Delivery Order
This is a $3,676.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 40 MG CAPSULE 30S, a prescription medication, with a performance period through July 23, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/1/25 |